Xiaobo Cheng
Impact in
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 7
- Fibroblast Growth Factor Research 7
- RNA Interference and Gene Delivery 2
- Cell Biology 11
- Proteoglycans and glycosaminoglycans research 10
- Co-authors
- Norihiro Sato (10 shared papers)Shiro Kohi (9 shared papers)Atsuhiro Koga (8 shared papers)Keiji Hirata (8 shared papers)Koji Yamaguchi (1 shared paper)Yanzhi Song (5 shared papers)Yihui Deng (6 shared papers)Zhenjun Huang (3 shared papers)
In The Last Decade
Xiaobo Cheng
21 papers receiving 617 citations
Peers
Comparison fields: 5 of 74
- Cell Biology 181
- Biomaterials 129
- Oncology 232
- Cancer Research 90
- Immunology 120
Countries citing papers authored by Xiaobo Cheng
This map shows the geographic impact of Xiaobo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Cheng more than expected).
Fields of papers citing papers by Xiaobo Cheng
This network shows the impact of papers produced by Xiaobo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Cheng. The network helps show where Xiaobo Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 94 | |
| 2 | 2014 | 59 | |
| 3 | 2015 | 59 | |
| 4 | 2016 | 58 | |
| 5 | 2016 | 54 | |
| 6 | 2015 | 53 | |
| 7 | 2018 | 48 | |
| 8 | 2015 | 36 | |
| 9 | 2013 | 24 | |
| 10 | 2015 | 22 | |
| 11 | 2018 | 20 | |
| 12 | 2016 | 19 | |
| 13 | 2013 | 19 | |
| 14 | 2018 | 15 | |
| 15 | 2016 | 10 | |
| 16 | 2019 | 9 | |
| 17 | 2025 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2020 | 3 |
About Xiaobo Cheng
Xiaobo Cheng is a scholar working on Molecular Biology, Cell Biology, Electrical and Electronic Engineering, Oncology and Biomaterials, having authored 22 papers that have together received 620 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (7 papers), Fibroblast Growth Factor Research (7 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Cells and Metastasis (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Electrocatalysts for Energy Conversion (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cell Biology (181 citations), Biomaterials (129 citations), Oncology (232 citations), Cancer Research (90 citations) and Immunology (120 citations). Xiaobo Cheng has collaborated with scholars based in China and Japan. Frequent co-authors include Norihiro Sato, Shiro Kohi, Atsuhiro Koga, Keiji Hirata, Koji Yamaguchi, Yanzhi Song, Yihui Deng, Zhenjun Huang, Xiang Luo and Zhennan She. Their work appears in journals such as Pancreatology, Clinical & Experimental Metastasis, Measurement, Acta Pharmaceutica Sinica B and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.